TheraRadar
Clinical-Stage Companies / Tasly Pharmaceutical Group

Tasly Pharmaceutical Group

Pre-Approval PRO BETA
30
Total Trials
10
Phase 3
16
Phase 2
11
Recruiting
340
Score

Pipeline by Phase

Phase 3
10
Phase 2
16
Phase 1
9

Therapeutic Focus

Depression Cough Heart Failure AMD Metastatic Castration-Resistant Prostate Cancer Patients

Clinical Trials (30)

NCT06696261 Phase 3 RECRUITING

A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome

Started: 2/27/2025

NCT06000956 Phase 3 RECRUITING

A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo

Started: 9/11/2023

NCT06697886 Phase 3 RECRUITING

A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

Started: 11/16/2023

NCT06685978 Phase 3 RECRUITING

Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands

Started: 4/26/2024

NCT07269769 Phase 3 NOT YET RECRUITING

A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD

Started: 4/30/2026

NCT06068478 Phase 3 COMPLETED

A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis

Started: 11/7/2023

NCT06068465 Phase 3 COMPLETED

A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Started: 9/27/2024

NCT06773117 Phase 3 NOT YET RECRUITING

Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment

Started: 9/1/2025

NCT06753890 Phase 3 NOT YET RECRUITING

Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)

Started: 12/30/2024

NCT06058546 Phase 2 RECRUITING

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Started: 11/23/2023

NCT05632861 Phase 2 RECRUITING

HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

Started: 2/21/2023

NCT07485595 Phase 2 NOT YET RECRUITING

A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression

Started: 4/30/2026

NCT06259526 Phase 2 COMPLETED

A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Started: 12/26/2023

NCT04983043 Phase 2 COMPLETED

Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure

Started: 6/10/2021

NCT04944706 Phase 2 COMPLETED

Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction

Started: 7/27/2021

NCT06669169 Phase 2 NOT YET RECRUITING

Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure

Started: 1/31/2025

NCT04492787 Phase 2 COMPLETED

Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Started: 7/6/2020

NCT04457011 Phase 2 COMPLETED

Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children

Started: 9/19/2020

NCT04229706 Phase 2 COMPLETED

A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)

Started: 12/31/2019

NCT04486963 Phase 2 COMPLETED

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Started: 7/24/2020

NCT03932019 Phase 2 COMPLETED

Study of Jitongning Tablet to Treat Spondyloarthritis

Started: 6/11/2019

NCT07514065 Phase 1 RECRUITING

TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Started: 2/20/2026

NCT07318818 Phase 1 RECRUITING

A Clinical Trial of P134 Cells in Recurrent Glioblastoma

Started: 1/5/2026

NCT07371624 Phase 1 RECRUITING

A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.

Started: 12/31/2025

NCT07265349 Phase 1 RECRUITING

A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure

Started: 12/26/2025

NCT06348498 Phase 1 RECRUITING

Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart Failure

Started: 4/9/2024

NCT06238687 Phase 1 COMPLETED

A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors

Started: 11/8/2023

NCT05656274 Phase 1 COMPLETED

A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.

Started: 11/29/2022

NCT04164290 Phase 1 COMPLETED

A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects

Started: 6/29/2020

NCT04471298 Phase 1 COMPLETED

A Study of Qishenyiqi Dripping Pills in Healthy Participants

Started: 9/21/2020

Drug Candidates

Placebo group JS1-1-01 low-dose group JS1-1-01 high-dose group Sanhuang Jingshiming/Pills placebo Treatment arm: TSL2109 capsules。Oral administration。 STRO-002 Qingzhu Granules Qingzhu Granules Placebo pimavanserin tartrate placebo
Activity Status: Active
Last Trial Started: 4/30/2026
Last Trial Ended: 2/1/2026
Trials (12 months): 7
Completed Trials: 14
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.